mumps virus vaccine

From Aaushi
Jump to navigation Jump to search
[1]

Introduction

Generally used in combination with other vaccines

Pathology

  • no evidence of emergence of resistant genotypes

Management

  • a 3rd vaccine dose around 18 years of age, with or without regular dosing in adulthood is suggested

Notes

  • vaccine protection seems to last an average of 27 years after the last dose (from mathematical models of outbreaks)
  • among people with an immune response to the vaccine, 25% may lose protection by 8 years, 50% by 19 years, & 75% by 38 years (not clear if this is disappearingcirculating IgG or mathematical models of outbreaks)

More general terms

Additional terms

Component of

References

  1. ↑ Lewnard JA, Grad YH Vaccine waning and mumps re-emergence in the United States. Sci Transl Med. 2018 Mar 21;10(433) Vol. 10, Issue 433, eaao5945 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29563321 <Internet> http://stm.sciencemag.org/content/10/433/eaao5945
Retrieved from "https://aaushi.info/w/index.php?title=A353506&oldid=1223352"